Beta Bionics, Inc. (BBNX)
19.42
-0.50
(-2.51%)
USD |
NASDAQ |
Sep 04, 16:00
19.41
-0.01
(-0.05%)
After-Hours: 20:00
Beta Bionics Shareholders Equity (Quarterly) : 256.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 256.37M |
| March 31, 2026 | 271.24M |
| December 31, 2025 | 287.61M |
| September 30, 2025 | 294.76M |
| June 30, 2025 | 301.63M |
| March 31, 2025 | 313.75M |
| Date | Value |
|---|---|
| December 31, 2024 | 76.01M |
| September 30, 2024 | 32.87M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 58.61M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.62B |
| Intuitive Surgical, Inc. | 18.17B |
| Kewaunee Scientific Corp. | 74.72M |
| STAAR Surgical Co. | 365.40M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 292.39M |
| Total Liabilities (Quarterly) | 36.02M |
| Debt to Equity Ratio | 0.0254 |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.01% |